Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jul 1;88(13):5842-6.
doi: 10.1073/pnas.88.13.5842.

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease

Affiliations

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease

C R Harrington et al. Proc Natl Acad Sci U S A. .

Abstract

The tau protein is a microtubule-associated protein that is normally located in nerve axons. In Alzheimer disease, it is a constituent of paired helical filaments (PHFs), which are the principal fibrous component of the characteristic neurofibrillary tangles. The tau protein, therefore, is abnormally sequestered in an insoluble form in PHFs in the cell body and dendrites in Alzheimer disease. We have used two monoclonal antibodies (mAbs) to selectively measure the levels of normal, soluble tau protein and of PHF-associated tau protein in the brain. mAb 423 binds to PHFs and recognizes a 12-kDa fragment of tau protein released by formic acid treatment of PHFs, but it does not recognize normal tau protein. In contrast, mAb 7.51 recognizes normal tau protein as well as the PHF core-derived tau fragment, but its epitope is concealed in the PHF-bound form. The differential binding properties for these two mAbs have enabled us in this study to quantify insoluble PHF-associated tau protein in the somatodendritic compartment as well as normal soluble tau protein in its predominantly axonal location. Our findings demonstrate that a distinct immunochemical presentation of tau protein recognized by mAb 423, a PHF-specific marker, can be used to quantify neurofibrillary pathology in Alzheimer disease independently of the presence of normal tau proteins.

PubMed Disclaimer

References

    1. Nature. 1963 Jan 12;197:192-3 - PubMed
    1. Proc R Soc Med. 1967 Mar;60(3):254-60 - PubMed
    1. J Immunol Methods. 1990 Dec 5;134(2):261-71 - PubMed
    1. Neuron. 1989 Oct;3(4):519-26 - PubMed
    1. J Cell Biol. 1985 Jun;100(6):1905-12 - PubMed

Publication types